Literature DB >> 29656404

Pyoderma gangrenosum in an infant: A case report and review of the literature.

Lauren Crouse1, Diana McShane1, Dean S Morrell1, Eveline Y Wu1.   

Abstract

Pyoderma gangrenosum is a neutrophilic dermatosis that is rare in infancy, with only 20 cases reported in the literature. We present a case of infantile pyoderma gangrenosum refractory to topical steroids, tacrolimus, and dapsone as well as systemic steroids and infliximab that is currently well controlled with the addition of oral tacrolimus. To our knowledge, this is the first report of the effective, safe use of oral tacrolimus in combination with infliximab for infantile pyoderma gangrenosum. We review all current cases of infantile pyoderma gangrenosum, as well as tacrolimus and its role in the treatment of this condition.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  inflammatory disorders; therapy-systemic

Mesh:

Substances:

Year:  2018        PMID: 29656404     DOI: 10.1111/pde.13471

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  2 in total

1.  Successful Treatment of PAPA Syndrome with Dual Adalimumab and Tacrolimus Therapy.

Authors:  Amika K Sood; Diana B McShane; Paul B Googe; Eveline Y Wu
Journal:  J Clin Immunol       Date:  2019-08-30       Impact factor: 8.317

2.  Oral tacrolimus for ocular involvement in pediatric neutrophilic dermatoses.

Authors:  Caitlan Swaffar; Diana McShane; Paul Googe; Leonard Kovalick; Dean S Morrell; Eveline Y Wu
Journal:  JAAD Case Rep       Date:  2022-01-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.